细胞因子在胆管癌组织中的表达及与小肠细菌过度生长的关系探讨
Study on the Relation between the Overexpression of Cytokines and Small Intestinal Bacterial Overgrowth in Cholangiocarcinoma
DOI: 10.12677/ACM.2021.111003, PDF,   
作者: 刘亚楠, 马晓莹, 徐 豪, 许 琳:青岛大学附属青岛市市立医院,山东 青岛
关键词: 胆管癌小肠细菌过度生长细胞因子Cholangiocarcinoma Small Intestinal Bacteria Overgrowth Cytokines
摘要: 目的 本研究通过检测胆管癌(CCA)患者小肠细菌过度生长(small intestinal bacterial overgrowth, SIBO)及胆管癌组织中细胞因子(IL-1β、IL-6和TNF-α)的表达水平,来探讨胆管癌患者中小肠细菌过度生长的发病率及其与炎症介质水平的关系。方法:在30例胆管癌患者及30例健康对照中使用葡萄糖氢呼气实验(glucose hydrogen breath test, GHBT)检测小肠细菌过度生长的发生情况;采用免疫组织化学技术(immunohistochemistry, IHC)检测胆管癌组织中IL-1β、IL-6和TNF-α的表达情况。结果:1) 胆管癌组SIBO阳性率为53.3%,健康对照组SIBO阳性率为16.7%,胆管癌组SIBO阳性率明显高于对照组(X2 = 8.864, P < 0.05)。2) 在胆管癌患者SIBO阳性组和阴性组间IL-1β、IL-6、TNF-α的表达水平有显著差异(P = 0.03, 0.024, 0.01)。结论:胆管癌患者较健康人群更容易发生SIBO,SIBO可能通过促进IL-1β、IL-6及TNF-α的表达影响胰腺癌的发生发展。
Abstract: Objective: In this work, we investigated the morbidity of small intestinal bacterial overgrowth (SIBO) and the expression of cytokines (IL-1β, IL-6 and TNF-α) level in CCA, to analyze the changes between SIBO and inflammatory medium level. Methods: 30 patients with CCA and 30 healthy controls were included in this study. Glucose hydrogen breath test (GHBT) was used to detect SIBO. The immunohistochemistry (IHC) was used to detect the expression of IL-1β, IL-6 and TNF-α in CCA tissues. Results: 1) The SIBO positive rate was 53.3% in 30 patients with CCA, and 16.7% in 30 healthy controls. The SIBO positive rate was significantly higher in the CCA group than in the control group (X2 = 8.864, P < 0.05). 2) The expression levels of IL-1β, IL-6, TNF-α were significantly different between the SIBO(+) group and the SIBO(−) group in patients with CCA (P = 0.03, 0.024, 0.01). Conclusions: Patients with CCA were more likely to develop SIBO than healthy people. SIBO may influence the development of CCA by promoting the expression of IL-1β, IL-6 and TNF-α.
文章引用:刘亚楠, 马晓莹, 徐豪, 许琳. 细胞因子在胆管癌组织中的表达及与小肠细菌过度生长的关系探讨[J]. 临床医学进展, 2021, 11(1): 16-23. https://doi.org/10.12677/ACM.2021.111003

参考文献

[1] Ma, X., et al. (2019) Association between Small Intestinal Bacterial Overgrowth and Toll-Like Receptor 4 in Patients with Pancreatic Carcinoma and Cholangiocarcinoma. Turkish Journal of Gastroenterology, 30, 177-183. [Google Scholar] [CrossRef] [PubMed]
[2] 朱明亭, 郑心. 间质流膏对肺纤维化大鼠TGF-β1、TNF-α、PDGF-BB与α-SMA表达干预的实验研究[D]: [硕士学位论文]. 济南: 山东中医药大学中医内科学, 2011.
[3] Tyson, G.L. and El-Serag, H.B. (2011) Risk Factors for Cholangiocarcinoma. Hepatology, 54, 173-184. [Google Scholar] [CrossRef] [PubMed]
[4] 于兴华, 马晓莹, 许琳. 胆管癌化疗患者小肠细菌过度生长情况[J]. 中国微生态学杂志, 2019, 31(7): 803-807.
[5] Rezaie, A., Pimentel, M. and Rao, S. (2016) How to Test and Treat Small Intestinal Bacterial Overgrowth: An Evidence-Based Approach. Current Gastroenterology Reports, 18, 8. [Google Scholar] [CrossRef] [PubMed]
[6] Simrén, M. and Stotzer, P.O. (2006) Use and Abuse of Hydrogen Breath Tests. Gut, 55, 297-303. [Google Scholar] [CrossRef] [PubMed]
[7] Rezaie, A., Buresi, M., Lembo, A., et al. (2017) Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. The American Journal of Gastroenterology, 112, 775-784. [Google Scholar] [CrossRef] [PubMed]
[8] 王为, 刘峰, 徐爱蕾, 颜君, 蔡娜, 葛妍芹. 三种消化道恶性肿瘤小肠细菌过度生长情况的研究[J]. 医学综述, 2011, 17(6): 946-947.
[9] 刘扬, 李媛, 张东生, 张爱军, 许琳. 小肠细菌过度生长与小肠肿瘤的关系及其临床意义[J]. 世界华人消化杂志, 2013, 21(31): 3435-3439.
[10] Augustyn, M., Grys, I. and Kukla, M. (2019) Small Intestinal Bacterial Overgrowth and Nonalcoholic Fatty Liver Disease. Clinical and Experimental Hepatology, 5, 1-10. [Google Scholar] [CrossRef] [PubMed]
[11] Quigley, E.M., Stanton, C. and Murphy, E.F. (2013) The Gut Microbiota and the Liver. Pathophysiological and Clinical Implications. Journal of Hepatology, 58, 1020-1027. [Google Scholar] [CrossRef] [PubMed]
[12] 许春蕾, 李娜, 汤旭山. IL-1β通过上调CDC42/NF-κB信号通路促进胃癌细胞的增殖、迁移及侵袭[J]. 现代免疫学, 2020, 40(6): 441-445+53.
[13] 陆兴热, 陈凤羽, 杨德兴. IL-1β基因多态性及幽门螺杆菌感染交互作用与胃癌发生的相关性研究[J]. 中华医院感染学杂志, 2015, 25(10): 2185-2187.
[14] Buranrat, B., Prawan, A., Sripa, B. and Kukongviriyapan, V. (2007) Inflammatory Cytokines Suppress Arylamine N-Acetyltransferase 1 in Cholangiocarcinoma Cells. World Journal of Gastroenterology, 13, 6219-6225. [Google Scholar] [CrossRef] [PubMed]
[15] Isomoto, H., Kobayashi, S., Werneburg, N.W., et al. (2005) Interleukin 6 Upregulates Myeloid Cell Leukemia-1 Expression through a STAT3 Pathway in Cholangiocarcinoma Cells. Hepatology, 42, 1329-1338. [Google Scholar] [CrossRef] [PubMed]
[16] Isomoto, H., Mott, J.L., Kobayashi, S., et al. (2007) Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing. Gastroenterology, 132, 384-396. [Google Scholar] [CrossRef] [PubMed]
[17] Lv, B., Ma, L., Tang, W., et al. (2018) FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition. Cellular Physiology and Biochemistry, 48, 158-172. [Google Scholar] [CrossRef] [PubMed]
[18] Wehbe, H., Henson, R., Meng, F., Mize-Berge, J. and Patel, T. (2006) Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression. Cancer Research, 66, 10517-10524. [Google Scholar] [CrossRef
[19] Meng, F., Yamagiwa, Y., Ueno, Y. and Patel, T. (2006) Over-Expression of Interleukin-6 Enhances Cell Survival and Transformed Cell Growth in Human Malignant Cholangiocytes. Journal of Hepatology, 44, 1055-1065. [Google Scholar] [CrossRef] [PubMed]
[20] Braconi, C., Swenson, E., Kogure, T., Huang, N. and Patel, T. (2010) Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma. PLoS ONE, 5, e15195. [Google Scholar] [CrossRef] [PubMed]
[21] Loris, B. and Simone, M. (2010) The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology. Current Medicinal Chemistry, 17, 3337-3352. [Google Scholar] [CrossRef] [PubMed]
[22] Stanilov, N., Miteva, L., Dobreva, Z. and Stanilova, S. (2014) Colorectal Cancer Severity and Survival in Correlation with Tumour Necrosis Factor-Alpha. Biotechnology & Biotechnological Equipment, 28, 911-917. [Google Scholar] [CrossRef] [PubMed]
[23] Srivastava, D., Ghoshal, U., Mittal, R.D. and Ghoshal, U.C. (2014) Associations between IL-1RA Polymorphisms and Small Intestinal Bacterial Overgrowth among Patients with Irritable Bowel Syndrome from India. Neurogastroenterology & Motility, 26, 1408-1416. [Google Scholar] [CrossRef] [PubMed]
[24] 王锦辉, 陈旻湖, 何瑶. 肝硬化患者小肠细菌过度生长与内毒素血症[J]. 中华内科杂志, 2002, 41(7): 30-32.